ABSTRACT NUMBER: ESOC2026A1390 LESS IS MORE: THE NOTCH3-SVD STAGING SYSTEM VERSUS SERUM NEUROFILAMENT LIGHT AS A PREDICTOR FOR DISEASE PROGRESSION IN CADASIL

Abstract Background and aims Disease progression in the genetic small vessel disease (SVD) CADASIL is highly variable, and was recently captured using the NOTCH3-SVD staging system: a tool for uniform disease staging using routine clinical and neuroimaging measures. Previously, serum Neurofilament Light-chain (sNfL) has been shown to predict disease progression in CADASIL, but requires expensive ultrasensitive assays. Here, we examined the association between sNfL and disease progression in a 2-year follow-up study of CADASIL patients, accounting for the NOTCH3-SVD stages. Methods sNfL values were determined in 55 patients at baseline and 2-year follow-up, using Simoa. Associations of incident ischemic stroke, lacunes, and microbleeds, with baseline sNfL (model 1), sNfL and age (model 2), and sNfL, age and NOTCH3-SVD stage (model 3) were determined using generalized linear models, and expressed as odds ratios (OR, for 1 sd or stage). Results Baseline sNfL values were predictive for 2-year incident lacunes and microbleeds, but not for stroke (model 1). The predictive effect of sNfL decreased after adjusting for age (model 2). In a combined model with NOTCH3-SVD stage and age (model 3), sNfL values were not predictive of incident events, whereas NOTCH3-SVD stage was predictive of incident stroke, incident lacunes, and incident microbleeds. Conclusions In CADASIL, a clinico-neuroradiological staging system outperforms the ultrasensitive biomarker sNfL in disease prediction. This study illustrates that the predictive value of the sNfL is mediated through age and NOTCH3-SVD stage in CADASIL, and highlights the importance of accounting for NOTCH3-SVD stage in CADASIL biomarker studies. Conflict of interest G. Gravesteijn, R.J. Hack, M.N. Cerfontaine, M.J.A Koel-Simmelink, C. Teunissen, J.W. Rutten, S.A.J. Lesnik Oberstein: nothing to disclose relevant to this project.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.095
Primary Topic
Cerebrovascular and genetic disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1390 LESS IS MORE: THE NOTCH3-SVD STAGING SYSTEM VERSUS SERUM NEUROFILAMENT LIGHT AS A PREDICTOR FOR DISEASE PROGRESSION IN CADASIL

Julie W. Rutten, Minne N. Cerfontaine, Remco J. Hack, Gido Gravesteijn et al.
European Stroke Journal
Cerebrovascular and genetic disorders
article

ABSTRACT NUMBER: ESOC2026A1390 LESS IS MORE: THE NOTCH3-SVD STAGING SYSTEM VERSUS SERUM NEUROFILAMENT LIGHT AS A PREDICTOR FOR DISEASE PROGRESSION IN CADASIL

Julie W. Rutten, Minne N. Cerfontaine, Remco J. Hack, Gido Gravesteijn, Saskia Lesnik Oberstein, Marleen Koel-Simmelink, Charlotte Teunissen
article en

Abstract

Abstract Background and aims Disease progression in the genetic small vessel disease (SVD) CADASIL is highly variable, and was recently captured using the NOTCH3-SVD staging system: a tool for uniform disease staging using routine clinical and neuroimaging measures. Previously, serum Neurofilament Light-chain (sNfL) has been shown to predict disease progression in CADASIL, but requires expensive ultrasensitive assays. Here, we examined the association between sNfL and disease progression in a 2-year follow-up study of CADASIL patients, accounting for the NOTCH3-SVD stages. Methods sNfL values were determined in 55 patients at baseline and 2-year follow-up, using Simoa. Associations of incident ischemic stroke, lacunes, and microbleeds, with baseline sNfL (model 1), sNfL and age (model 2), and sNfL, age and NOTCH3-SVD stage (model 3) were determined using generalized linear models, and expressed as odds ratios (OR, for 1 sd or stage). Results Baseline sNfL values were predictive for 2-year incident lacunes and microbleeds, but not for stroke (model 1). The predictive effect of sNfL decreased after adjusting for age (model 2). In a combined model with NOTCH3-SVD stage and age (model 3), sNfL values were not predictive of incident events, whereas NOTCH3-SVD stage was predictive of incident stroke, incident lacunes, and incident microbleeds. Conclusions In CADASIL, a clinico-neuroradiological staging system outperforms the ultrasensitive biomarker sNfL in disease prediction. This study illustrates that the predictive value of the sNfL is mediated through age and NOTCH3-SVD stage in CADASIL, and highlights the importance of accounting for NOTCH3-SVD stage in CADASIL biomarker studies. Conflict of interest G. Gravesteijn, R.J. Hack, M.N. Cerfontaine, M.J.A Koel-Simmelink, C. Teunissen, J.W. Rutten, S.A.J. Lesnik Oberstein: nothing to disclose relevant to this project.

European Stroke JournalVol. 11(Supplement_1)
Leiden University Medical Center (NL), Amsterdam Neuroscience (NL)
Good health and well-being
Openalex Percentile: Top 10%
Cerebrovascular and genetic disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.